APO Research
Talk to an analyst

APO RESEARCH · REPORT

General Medicines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global General Medicines Industry Growth and Trends Forecast to 2032

29 December 2025127 pages

Choose your research edition.

Industry ResearchGeneral Medicines Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal General Medicines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal General Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal General Medicines Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal General Medicines Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global General Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for General Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for General Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for General Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of General Medicines include Sun Pharmaceutical, Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Eli Lilly, Pfizer and Jiangsu Hengrui Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global General Medicines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The General Medicines market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global General Medicines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to General Medicines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global General Medicines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

General Medicines Market by Company

Sun Pharmaceutical

Sanofi

Johnson & Johnson

Novartis

Merck

Roche

Eli Lilly

Pfizer

Jiangsu Hengrui Medicine

Bayer

Amgen

AbbVie

AstraZeneca

Zoetis

Vertex Pharmaceuticals

Takeda Pharmaceutical

Seagen

Regeneron Pharmaceuticals

Novo Nordisk

Moderna

Lonza

Horizon Therapeutics

GlaxoSmithKline

Gilead Sciences

Daiichi Sankyō

CVS Health

Chugai Pharmaceutical

Bristol-Myers Squibb

Biogen

Argenx

General Medicines Segment by Type

Over-the-Counter (OTC)

Prescription (Rx)

General Medicines Segment by Application

Antihypertensives

Antibiotics

Antidiabetic Drugs

Antipyretics

Analgesics

Others

General Medicines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of General Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of General Medicines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of General Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Over-the-Counter (OTC) Table 2. Major Company of Prescription (Rx) Table 3. Global General Medicines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global General Medicines Sales by Type (2021-2026) & (K Units) Table 5. Global General Medicines Sales Market Share in Volume by Type (2021-2026) Table 6. Global General Medicines Sales by Type (2021-2026) & (US$ Million) Table 7. Global General Medicines Sales Market Share in Value by Type (2021-2026) Table 8. Global General Medicines Price by Type (2021-2026) & (US$/Unit) Table 9. Global General Medicines Sales by Type (2027-2032) & (K Units) Table 10. Global General Medicines Sales Market Share in Volume by Type (2027-2032) Table 11. Global General Medicines Sales by Type (2027-2032) & (US$ Million) Table 12. Global General Medicines Sales Market Share in Value by Type (2027-2032) Table 13. Global General Medicines Price by Type (2027-2032) & (US$/Unit) Table 14. North America General Medicines Sales by Type (2021-2026) & (K Units) Table 15. North America General Medicines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe General Medicines Sales by Type (2021-2026) & (K Units) Table 17. Europe General Medicines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific General Medicines Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific General Medicines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America General Medicines Sales by Type (2021-2026) & (K Units) Table 21. Latin America General Medicines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa General Medicines Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa General Medicines Sales by Type (2021-2026) & (US$ Million) Table 24. General Medicines Industry Trends Table 25. General Medicines Industry Drivers Table 26. General Medicines Industry Opportunities and Challenges Table 27. General Medicines Industry Restraints Table 28. Global General Medicines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global General Medicines Revenue Market Share by Company (2021-2026) Table 30. Global General Medicines Sales by Company (2021-2026) & (K Units) Table 31. Global General Medicines Sales Share by Company (2021-2026) Table 32. Global General Medicines Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global General Medicines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global General Medicines Major Company Production Sites and Headquarters Table 35. Global General Medicines Company, Product Type & Application Table 36. Global General Medicines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global General Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global General Medicines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global General Medicines Sales by Region (2021-2026) & (K Units) Table 41. Global General Medicines Sales Market Share in Volume by Region (2021-2026) Table 42. Global General Medicines Sales by Region (2021-2026) & (US$ Million) Table 43. Global General Medicines Sales Market Share in Value by Region (2021-2026) Table 44. Global General Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global General Medicines Sales by Region (2027-2032) & (K Units) Table 46. Global General Medicines Sales Market Share in Volume by Region (2027-2032) Table 47. Global General Medicines Sales by Region (2027-2032) & (US$ Million) Table 48. Global General Medicines Sales Market Share in Value by Region (2027-2032) Table 49. Global General Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global General Medicines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global General Medicines Sales by Application (2021-2026) & (K Units) Table 52. Global General Medicines Sales Market Share in Volume by Application (2021-2026) Table 53. Global General Medicines Sales by Application (2021-2026) & (US$ Million) Table 54. Global General Medicines Sales Market Share in Value by Application (2021-2026) Table 55. Global General Medicines Price by Application (2021-2026) & (US$/Unit) Table 56. Global General Medicines Sales by Application (2027-2032) & (K Units) Table 57. Global General Medicines Sales Market Share in Volume by Application (2027-2032) Table 58. Global General Medicines Sales by Application (2027-2032) & (US$ Million) Table 59. Global General Medicines Sales Market Share in Value by Application (2027-2032) Table 60. Global General Medicines Price by Application (2027-2032) & (US$/Unit) Table 61. North America General Medicines Sales by Application (2021-2026) & (K Units) Table 62. North America General Medicines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe General Medicines Sales by Application (2021-2026) & (K Units) Table 64. Europe General Medicines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific General Medicines Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific General Medicines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America General Medicines Sales by Application (2021-2026) & (K Units) Table 68. Latin America General Medicines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa General Medicines Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa General Medicines Sales by Application (2021-2026) & (US$ Million) Table 71. Sun Pharmaceutical Company Information Table 72. Sun Pharmaceutical Business Overview Table 73. Sun Pharmaceutical General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sun Pharmaceutical General Medicines Product Portfolio Table 75. Sun Pharmaceutical Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sanofi General Medicines Product Portfolio Table 80. Sanofi Recent Development Table 81. Johnson & Johnson Company Information Table 82. Johnson & Johnson Business Overview Table 83. Johnson & Johnson General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Johnson & Johnson General Medicines Product Portfolio Table 85. Johnson & Johnson Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Novartis General Medicines Product Portfolio Table 90. Novartis Recent Development Table 91. Merck Company Information Table 92. Merck Business Overview Table 93. Merck General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Merck General Medicines Product Portfolio Table 95. Merck Recent Development Table 96. Roche Company Information Table 97. Roche Business Overview Table 98. Roche General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Roche General Medicines Product Portfolio Table 100. Roche Recent Development Table 101. Eli Lilly Company Information Table 102. Eli Lilly Business Overview Table 103. Eli Lilly General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Eli Lilly General Medicines Product Portfolio Table 105. Eli Lilly Recent Development Table 106. Pfizer Company Information Table 107. Pfizer Business Overview Table 108. Pfizer General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Pfizer General Medicines Product Portfolio Table 110. Pfizer Recent Development Table 111. Jiangsu Hengrui Medicine Company Information Table 112. Jiangsu Hengrui Medicine Business Overview Table 113. Jiangsu Hengrui Medicine General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Jiangsu Hengrui Medicine General Medicines Product Portfolio Table 115. Jiangsu Hengrui Medicine Recent Development Table 116. Bayer Company Information Table 117. Bayer Business Overview Table 118. Bayer General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Bayer General Medicines Product Portfolio Table 120. Bayer Recent Development Table 121. Amgen Company Information Table 122. Amgen Business Overview Table 123. Amgen General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Amgen General Medicines Product Portfolio Table 125. Amgen Recent Development Table 126. AbbVie Company Information Table 127. AbbVie Business Overview Table 128. AbbVie General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. AbbVie General Medicines Product Portfolio Table 130. AbbVie Recent Development Table 131. AstraZeneca Company Information Table 132. AstraZeneca Business Overview Table 133. AstraZeneca General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. AstraZeneca General Medicines Product Portfolio Table 135. AstraZeneca Recent Development Table 136. Zoetis Company Information Table 137. Zoetis Business Overview Table 138. Zoetis General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Zoetis General Medicines Product Portfolio Table 140. Zoetis Recent Development Table 141. Vertex Pharmaceuticals Company Information Table 142. Vertex Pharmaceuticals Business Overview Table 143. Vertex Pharmaceuticals General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Vertex Pharmaceuticals General Medicines Product Portfolio Table 145. Vertex Pharmaceuticals Recent Development Table 146. Takeda Pharmaceutical Company Information Table 147. Takeda Pharmaceutical Business Overview Table 148. Takeda Pharmaceutical General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Takeda Pharmaceutical General Medicines Product Portfolio Table 150. Takeda Pharmaceutical Recent Development Table 151. Seagen Company Information Table 152. Seagen Business Overview Table 153. Seagen General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Seagen General Medicines Product Portfolio Table 155. Seagen Recent Development Table 156. Regeneron Pharmaceuticals Company Information Table 157. Regeneron Pharmaceuticals Business Overview Table 158. Regeneron Pharmaceuticals General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Regeneron Pharmaceuticals General Medicines Product Portfolio Table 160. Regeneron Pharmaceuticals Recent Development Table 161. Novo Nordisk Company Information Table 162. Novo Nordisk Business Overview Table 163. Novo Nordisk General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Novo Nordisk General Medicines Product Portfolio Table 165. Novo Nordisk Recent Development Table 166. Moderna Company Information Table 167. Moderna Business Overview Table 168. Moderna General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Moderna General Medicines Product Portfolio Table 170. Moderna Recent Development Table 171. Lonza Company Information Table 172. Lonza Business Overview Table 173. Lonza General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Lonza General Medicines Product Portfolio Table 175. Lonza Recent Development Table 176. Horizon Therapeutics Company Information Table 177. Horizon Therapeutics Business Overview Table 178. Horizon Therapeutics General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 179. Horizon Therapeutics General Medicines Product Portfolio Table 180. Horizon Therapeutics Recent Development Table 181. GlaxoSmithKline Company Information Table 182. GlaxoSmithKline Business Overview Table 183. GlaxoSmithKline General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 184. GlaxoSmithKline General Medicines Product Portfolio Table 185. GlaxoSmithKline Recent Development Table 186. Gilead Sciences Company Information Table 187. Gilead Sciences Business Overview Table 188. Gilead Sciences General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 189. Gilead Sciences General Medicines Product Portfolio Table 190. Gilead Sciences Recent Development Table 191. Daiichi Sankyō Company Information Table 192. Daiichi Sankyō Business Overview Table 193. Daiichi Sankyō General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 194. Daiichi Sankyō General Medicines Product Portfolio Table 195. Daiichi Sankyō Recent Development Table 196. CVS Health Company Information Table 197. CVS Health Business Overview Table 198. CVS Health General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 199. CVS Health General Medicines Product Portfolio Table 200. CVS Health Recent Development Table 201. Chugai Pharmaceutical Company Information Table 202. Chugai Pharmaceutical Business Overview Table 203. Chugai Pharmaceutical General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 204. Chugai Pharmaceutical General Medicines Product Portfolio Table 205. Chugai Pharmaceutical Recent Development Table 206. Bristol-Myers Squibb Company Information Table 207. Bristol-Myers Squibb Business Overview Table 208. Bristol-Myers Squibb General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 209. Bristol-Myers Squibb General Medicines Product Portfolio Table 210. Bristol-Myers Squibb Recent Development Table 211. Biogen Company Information Table 212. Biogen Business Overview Table 213. Biogen General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 214. Biogen General Medicines Product Portfolio Table 215. Biogen Recent Development Table 216. Argenx Company Information Table 217. Argenx Business Overview Table 218. Argenx General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 219. Argenx General Medicines Product Portfolio Table 220. Argenx Recent Development Table 221. North America General Medicines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 222. North America General Medicines Sales by Country (2021-2026) & (K Units) Table 223. North America General Medicines Sales Market Share by Country (2021-2026) Table 224. North America General Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 225. North America General Medicines Sales Market Share Forecast by Country (2027-2032) Table 226. North America General Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 227. North America General Medicines Market Size by Country (2021-2026) & (US$ Million) Table 228. North America General Medicines Market Share by Country (2021-2026) Table 229. North America General Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 230. North America General Medicines Market Share Forecast by Country (2027-2032) Table 231. Europe General Medicines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 232. Europe General Medicines Sales by Country (2021-2026) & (K Units) Table 233. Europe General Medicines Sales Market Share by Country (2021-2026) Table 234. Europe General Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 235. Europe General Medicines Sales Market Share Forecast by Country (2027-2032) Table 236. Europe General Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 237. Europe General Medicines Market Size by Country (2021-2026) & (US$ Million) Table 238. Europe General Medicines Market Share by Country (2021-2026) Table 239. Europe General Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 240. Europe General Medicines Market Share Forecast by Country (2027-2032) Table 241. Asia-Pacific General Medicines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 242. Asia-Pacific General Medicines Sales by Country (2021-2026) & (K Units) Table 243. Asia-Pacific General Medicines Sales Market Share by Country (2021-2026) Table 244. Asia-Pacific General Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 245. Asia-Pacific General Medicines Sales Market Share Forecast by Country (2027-2032) Table 246. Asia-Pacific General Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 247. Asia-Pacific General Medicines Market Size by Country (2021-2026) & (US$ Million) Table 248. Asia-Pacific General Medicines Market Share by Country (2021-2026) Table 249. Asia-Pacific General Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 250. Asia-Pacific General Medicines Market Share Forecast by Country (2027-2032) Table 251. Latin America General Medicines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 252. Latin America General Medicines Sales by Country (2021-2026) & (K Units) Table 253. Latin America General Medicines Sales Market Share by Country (2021-2026) Table 254. Latin America General Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 255. Latin America General Medicines Sales Market Share Forecast by Country (2027-2032) Table 256. Latin America General Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 257. Latin America General Medicines Market Size by Country (2021-2026) & (US$ Million) Table 258. Latin America General Medicines Market Share by Country (2021-2026) Table 259. Latin America General Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 260. Latin America General Medicines Market Share Forecast by Country (2027-2032) Table 261. Middle East and Africa General Medicines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 262. Middle East and Africa General Medicines Sales by Country (2021-2026) & (K Units) Table 263. Middle East and Africa General Medicines Sales Market Share by Country (2021-2026) Table 264. Middle East and Africa General Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 265. Middle East and Africa General Medicines Sales Market Share Forecast by Country (2027-2032) Table 266. Middle East and Africa General Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 267. Middle East and Africa General Medicines Market Size by Country (2021-2026) & (US$ Million) Table 268. Middle East and Africa General Medicines Market Share by Country (2021-2026) Table 269. Middle East and Africa General Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 270. Middle East and Africa General Medicines Market Share Forecast by Country (2027-2032) Table 271. Key Raw Materials Table 272. Raw Materials Key Suppliers Table 273. General Medicines Distributors List Table 274. General Medicines Customers List Table 275. Research Programs/Design for This Report Table 276. Authors List of This Report Table 277. Secondary Sources Table 278. Primary Sources List of Figures Figure 1. General Medicines Image Figure 2. Global General Medicines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global General Medicines Market Size (2021-2032) & (US$ Million) Figure 4. Global General Medicines Sales (2021-2032) & (K Units) Figure 5. Over-the-Counter (OTC) Image Figure 6. Global Over-the-Counter (OTC) Sales YoY Growth (2021-2032) & (K Units) Figure 7. Prescription (Rx) Image Figure 8. Global Prescription (Rx) Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global General Medicines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global General Medicines Market Share by Type 2025 VS 2032 Figure 11. North America General Medicines Sales Market Share in Volume by Type in 2025 Figure 12. North America General Medicines Sales Market Share in Value by Type in 2025 Figure 13. Europe General Medicines Sales Market Share in Volume by Type in 2025 Figure 14. Europe General Medicines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific General Medicines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific General Medicines Sales Market Share in Value by Type in 2025 Figure 17. Latin America General Medicines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America General Medicines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa General Medicines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa General Medicines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 General Medicines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Antihypertensives Image Figure 24. Global Antihypertensives Sales YoY Growth (2021-2032) & (K Units) Figure 25. Antibiotics Image Figure 26. Global Antibiotics Sales YoY Growth (2021-2032) & (K Units) Figure 27. Antidiabetic Drugs Image Figure 28. Global Antidiabetic Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 29. Antipyretics Image Figure 30. Global Antipyretics Sales YoY Growth (2021-2032) & (K Units) Figure 31. Analgesics Image Figure 32. Global Analgesics Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global General Medicines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global General Medicines Market Share by Application 2025 VS 2032 Figure 37. North America General Medicines Sales Market Share in Volume by Application in 2025 Figure 38. North America General Medicines Sales Market Share in Value by Application in 2025 Figure 39. Europe General Medicines Sales Market Share in Volume by Application in 2025 Figure 40. Europe General Medicines Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific General Medicines Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific General Medicines Sales Market Share in Value by Application in 2025 Figure 43. Latin America General Medicines Sales Market Share in Volume by Application in 2025 Figure 44. Latin America General Medicines Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa General Medicines Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa General Medicines Sales Market Share in Value by Application in 2025 Figure 47. North America General Medicines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America General Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America General Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America General Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe General Medicines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe General Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe General Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe General Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific General Medicines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific General Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific General Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific General Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America General Medicines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America General Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America General Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America General Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa General Medicines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa General Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa General Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa General Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. General Medicines Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. General Medicines Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Over-the-Counter (OTC)
  • Prescription (Rx)
Applications
  • Antihypertensives
  • Antibiotics
  • Antidiabetic Drugs
  • Antipyretics
  • Analgesics
  • Others
Companies covered
  • Sun Pharmaceutical
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Roche
  • Eli Lilly
  • Pfizer
  • Jiangsu Hengrui Medicine
  • Bayer
  • Amgen
  • AbbVie
  • AstraZeneca
  • Zoetis
  • Vertex Pharmaceuticals
  • Takeda Pharmaceutical
  • Seagen
  • Regeneron Pharmaceuticals
  • Novo Nordisk
  • Moderna
  • Lonza
  • Horizon Therapeutics
  • GlaxoSmithKline
  • Gilead Sciences
  • Daiichi Sankyō
  • CVS Health
  • Chugai Pharmaceutical
  • Bristol-Myers Squibb
  • Biogen
  • Argenx

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global General Medicines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global General Medicines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 General Medicines Market by Type
  6. 1.3.1 Over-the-Counter (OTC)
  7. 1.3.2 Prescription (Rx)
  8. 1.4 Global General Medicines Market Size by Type
  9. 1.4.1 Global General Medicines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global General Medicines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global General Medicines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America General Medicines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe General Medicines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific General Medicines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America General Medicines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa General Medicines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 General Medicines Industry Trends
  2. 2.2 General Medicines Industry Drivers
  3. 2.3 General Medicines Industry Opportunities and Challenges
  4. 2.4 General Medicines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by General Medicines Revenue (2021-2026)
  2. 3.2 Global Top Players by General Medicines Sales (2021-2026)
  3. 3.3 Global Top Players by General Medicines Price (2021-2026)
  4. 3.4 Global General Medicines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global General Medicines Major Company Production Sites & Headquarters
  6. 3.6 Global General Medicines Company, Product Type & Application
  7. 3.7 Global General Medicines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global General Medicines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 General Medicines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 General Medicines Tier 1, Tier 2, and Tier 3
4 General Medicines Regional Status and Outlook
  1. 4.1 Global General Medicines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global General Medicines Historic Market Size by Region
  3. 4.2.1 Global General Medicines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global General Medicines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global General Medicines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global General Medicines Forecasted Market Size by Region
  7. 4.3.1 Global General Medicines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global General Medicines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global General Medicines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 General Medicines by Application
  1. 5.1 General Medicines Market by Application
  2. 5.1.1 Antihypertensives
  3. 5.1.2 Antibiotics
  4. 5.1.3 Antidiabetic Drugs
  5. 5.1.4 Antipyretics
  6. 5.1.5 Analgesics
  7. 5.1.6 Others
  8. 5.2 Global General Medicines Market Size by Application
  9. 5.2.1 Global General Medicines Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global General Medicines Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global General Medicines Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America General Medicines Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe General Medicines Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific General Medicines Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America General Medicines Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa General Medicines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sun Pharmaceutical
  2. 6.1.1 Sun Pharmaceutical Company Information
  3. 6.1.2 Sun Pharmaceutical Business Overview
  4. 6.1.3 Sun Pharmaceutical General Medicines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sun Pharmaceutical General Medicines Product Portfolio
  6. 6.1.5 Sun Pharmaceutical Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi General Medicines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi General Medicines Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson General Medicines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson General Medicines Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis General Medicines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis General Medicines Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck General Medicines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck General Medicines Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche General Medicines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Roche General Medicines Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Eli Lilly
  38. 6.7.1 Eli Lilly Company Information
  39. 6.7.2 Eli Lilly Business Overview
  40. 6.7.3 Eli Lilly General Medicines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Eli Lilly General Medicines Product Portfolio
  42. 6.7.5 Eli Lilly Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer General Medicines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer General Medicines Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Jiangsu Hengrui Medicine
  50. 6.9.1 Jiangsu Hengrui Medicine Company Information
  51. 6.9.2 Jiangsu Hengrui Medicine Business Overview
  52. 6.9.3 Jiangsu Hengrui Medicine General Medicines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu Hengrui Medicine General Medicines Product Portfolio
  54. 6.9.5 Jiangsu Hengrui Medicine Recent Developments
  55. 6.10 Bayer
  56. 6.10.1 Bayer Company Information
  57. 6.10.2 Bayer Business Overview
  58. 6.10.3 Bayer General Medicines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bayer General Medicines Product Portfolio
  60. 6.10.5 Bayer Recent Developments
  61. 6.11 Amgen
  62. 6.11.1 Amgen Company Information
  63. 6.11.2 Amgen Business Overview
  64. 6.11.3 Amgen General Medicines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Amgen General Medicines Product Portfolio
  66. 6.11.5 Amgen Recent Developments
  67. 6.12 AbbVie
  68. 6.12.1 AbbVie Company Information
  69. 6.12.2 AbbVie Business Overview
  70. 6.12.3 AbbVie General Medicines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 AbbVie General Medicines Product Portfolio
  72. 6.12.5 AbbVie Recent Developments
  73. 6.13 AstraZeneca
  74. 6.13.1 AstraZeneca Company Information
  75. 6.13.2 AstraZeneca Business Overview
  76. 6.13.3 AstraZeneca General Medicines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 AstraZeneca General Medicines Product Portfolio
  78. 6.13.5 AstraZeneca Recent Developments
  79. 6.14 Zoetis
  80. 6.14.1 Zoetis Company Information
  81. 6.14.2 Zoetis Business Overview
  82. 6.14.3 Zoetis General Medicines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Zoetis General Medicines Product Portfolio
  84. 6.14.5 Zoetis Recent Developments
  85. 6.15 Vertex Pharmaceuticals
  86. 6.15.1 Vertex Pharmaceuticals Company Information
  87. 6.15.2 Vertex Pharmaceuticals Business Overview
  88. 6.15.3 Vertex Pharmaceuticals General Medicines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Vertex Pharmaceuticals General Medicines Product Portfolio
  90. 6.15.5 Vertex Pharmaceuticals Recent Developments
  91. 6.16 Takeda Pharmaceutical
  92. 6.16.1 Takeda Pharmaceutical Company Information
  93. 6.16.2 Takeda Pharmaceutical Business Overview
  94. 6.16.3 Takeda Pharmaceutical General Medicines Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Takeda Pharmaceutical General Medicines Product Portfolio
  96. 6.16.5 Takeda Pharmaceutical Recent Developments
  97. 6.17 Seagen
  98. 6.17.1 Seagen Company Information
  99. 6.17.2 Seagen Business Overview
  100. 6.17.3 Seagen General Medicines Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Seagen General Medicines Product Portfolio
  102. 6.17.5 Seagen Recent Developments
  103. 6.18 Regeneron Pharmaceuticals
  104. 6.18.1 Regeneron Pharmaceuticals Company Information
  105. 6.18.2 Regeneron Pharmaceuticals Business Overview
  106. 6.18.3 Regeneron Pharmaceuticals General Medicines Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Regeneron Pharmaceuticals General Medicines Product Portfolio
  108. 6.18.5 Regeneron Pharmaceuticals Recent Developments
  109. 6.19 Novo Nordisk
  110. 6.19.1 Novo Nordisk Company Information
  111. 6.19.2 Novo Nordisk Business Overview
  112. 6.19.3 Novo Nordisk General Medicines Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Novo Nordisk General Medicines Product Portfolio
  114. 6.19.5 Novo Nordisk Recent Developments
  115. 6.20 Moderna
  116. 6.20.1 Moderna Company Information
  117. 6.20.2 Moderna Business Overview
  118. 6.20.3 Moderna General Medicines Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Moderna General Medicines Product Portfolio
  120. 6.20.5 Moderna Recent Developments
  121. 6.21 Lonza
  122. 6.21.1 Lonza Company Information
  123. 6.21.2 Lonza Business Overview
  124. 6.21.3 Lonza General Medicines Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Lonza General Medicines Product Portfolio
  126. 6.21.5 Lonza Recent Developments
  127. 6.22 Horizon Therapeutics
  128. 6.22.1 Horizon Therapeutics Company Information
  129. 6.22.2 Horizon Therapeutics Business Overview
  130. 6.22.3 Horizon Therapeutics General Medicines Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Horizon Therapeutics General Medicines Product Portfolio
  132. 6.22.5 Horizon Therapeutics Recent Developments
  133. 6.23 GlaxoSmithKline
  134. 6.23.1 GlaxoSmithKline Company Information
  135. 6.23.2 GlaxoSmithKline Business Overview
  136. 6.23.3 GlaxoSmithKline General Medicines Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 GlaxoSmithKline General Medicines Product Portfolio
  138. 6.23.5 GlaxoSmithKline Recent Developments
  139. 6.24 Gilead Sciences
  140. 6.24.1 Gilead Sciences Company Information
  141. 6.24.2 Gilead Sciences Business Overview
  142. 6.24.3 Gilead Sciences General Medicines Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Gilead Sciences General Medicines Product Portfolio
  144. 6.24.5 Gilead Sciences Recent Developments
  145. 6.25 Daiichi Sankyō
  146. 6.25.1 Daiichi Sankyō Company Information
  147. 6.25.2 Daiichi Sankyō Business Overview
  148. 6.25.3 Daiichi Sankyō General Medicines Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Daiichi Sankyō General Medicines Product Portfolio
  150. 6.25.5 Daiichi Sankyō Recent Developments
  151. 6.26 CVS Health
  152. 6.26.1 CVS Health Company Information
  153. 6.26.2 CVS Health Business Overview
  154. 6.26.3 CVS Health General Medicines Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 CVS Health General Medicines Product Portfolio
  156. 6.26.5 CVS Health Recent Developments
  157. 6.27 Chugai Pharmaceutical
  158. 6.27.1 Chugai Pharmaceutical Company Information
  159. 6.27.2 Chugai Pharmaceutical Business Overview
  160. 6.27.3 Chugai Pharmaceutical General Medicines Sales, Revenue and Gross Margin (2021-2026)
  161. 6.27.4 Chugai Pharmaceutical General Medicines Product Portfolio
  162. 6.27.5 Chugai Pharmaceutical Recent Developments
  163. 6.28 Bristol-Myers Squibb
  164. 6.28.1 Bristol-Myers Squibb Company Information
  165. 6.28.2 Bristol-Myers Squibb Business Overview
  166. 6.28.3 Bristol-Myers Squibb General Medicines Sales, Revenue and Gross Margin (2021-2026)
  167. 6.28.4 Bristol-Myers Squibb General Medicines Product Portfolio
  168. 6.28.5 Bristol-Myers Squibb Recent Developments
  169. 6.29 Biogen
  170. 6.29.1 Biogen Company Information
  171. 6.29.2 Biogen Business Overview
  172. 6.29.3 Biogen General Medicines Sales, Revenue and Gross Margin (2021-2026)
  173. 6.29.4 Biogen General Medicines Product Portfolio
  174. 6.29.5 Biogen Recent Developments
  175. 6.30 Argenx
  176. 6.30.1 Argenx Company Information
  177. 6.30.2 Argenx Business Overview
  178. 6.30.3 Argenx General Medicines Sales, Revenue and Gross Margin (2021-2026)
  179. 6.30.4 Argenx General Medicines Product Portfolio
  180. 6.30.5 Argenx Recent Developments
7 North America by Country
  1. 7.1 North America General Medicines Sales by Country
  2. 7.1.1 North America General Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America General Medicines Sales by Country (2021-2026)
  4. 7.1.3 North America General Medicines Sales Forecast by Country (2027-2032)
  5. 7.2 North America General Medicines Market Size by Country
  6. 7.2.1 North America General Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America General Medicines Market Size by Country (2021-2026)
  8. 7.2.3 North America General Medicines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe General Medicines Sales by Country
  2. 8.1.1 Europe General Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe General Medicines Sales by Country (2021-2026)
  4. 8.1.3 Europe General Medicines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe General Medicines Market Size by Country
  6. 8.2.1 Europe General Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe General Medicines Market Size by Country (2021-2026)
  8. 8.2.3 Europe General Medicines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific General Medicines Sales by Country
  2. 9.1.1 Asia-Pacific General Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific General Medicines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific General Medicines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific General Medicines Market Size by Country
  6. 9.2.1 Asia-Pacific General Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific General Medicines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific General Medicines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America General Medicines Sales by Country
  2. 10.1.1 South America General Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America General Medicines Sales by Country (2021-2026)
  4. 10.1.3 South America General Medicines Sales Forecast by Country (2027-2032)
  5. 10.2 South America General Medicines Market Size by Country
  6. 10.2.1 South America General Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America General Medicines Market Size by Country (2021-2026)
  8. 10.2.3 South America General Medicines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa General Medicines Sales by Country
  2. 11.1.1 Middle East and Africa General Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa General Medicines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa General Medicines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa General Medicines Market Size by Country
  6. 11.2.1 Middle East and Africa General Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa General Medicines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa General Medicines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 General Medicines Value Chain Analysis
  2. 12.1.1 General Medicines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 General Medicines Production Mode & Process
  7. 12.2 General Medicines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 General Medicines Distributors
  10. 12.2.3 General Medicines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst